Continuous glucose monitoring in well-controlled elderly patients with type 2 Diabetes Mellitus.
Recruiting
- Conditions
- Older well-controlled patients with type 2 Diabetes MellitusHypoglycaemia / hypoglycemie
- Registration Number
- NL-OMON21290
- Lead Sponsor
- Diabetes centre, Isala Clinics, Zwolle, the Netherlands
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 15
Inclusion Criteria
known type 2 diabetes mellitus;
- >70 years old;
- HbA1c <58 mmol/mol;
- Groningen Frailty Indicator score ≥4;
- treatment with:
• metformin only (any dosage); or
• metformin (any dosage) + gliclazide (any dosage); or
• metformin (any dosage) + glimepiride (any dosage).
Exclusion Criteria
- insufficient knowledge of the Dutch language to understand the requirements of the study;
- advanced dementia;
- known anemia;
- terminally ill or an estimated life expectancy <3 months.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hypoglycaemia < 3.0 mmol/L of at least 15 minutes.
- Secondary Outcome Measures
Name Time Method Hypoglycaemia < 3.5 mmol/L of at least 15 minutes.<br>Symptomatic hypoglycaemia (<3.5 mmol/L of at least 15 minutes in combination with complaints of hypoglycaemia).<br>